Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Internal Medicine Journal
|
September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Journal of Personalized Medicine
|
November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic
John P Parisot, Heather Thorne, Andrew Fellowes, et al.
Clinical Lung Cancer
|
September 20, 2024
Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator
Sanuki Tissera, Baki Billah, Margaret Brand, et al.
Clinical Colorectal Cancer
|
March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer
Hui-Li Wong, Belinda Lee, Kathryn Field, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study
Belinda Lee, Hui-Li Wong, Mark Tacey, et al.
Thoracic Cancer
|
September 11, 2025
Impact of Stage-Specific Guideline Concordant Treatment in Small Cell Lung Cancer in Victoria, Australia
Sanuki Tissera, Baki Billah, Md Nazmul Karim, et al.
Thoracic Cancer
|
February 23, 2026
The Association Between Health-Related Quality of Life Scores and Clinical Outcomes for People Living With Lung Cancer: An Australian Registry Cohort Study Using Patient-Reported Outcomes to Drive Value-Based Healthcare
Susan V Harden, Madeleine T King, Jing Jing Li, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
Luis Paz-Ares, Remi Veillon, Margarita Majem, et al.
Nature Medicine
|
April 29, 2025
D3S-001 in advanced solid tumors with KRAS<sup>G12C</sup> mutations: a phase 1 trial
Byoung Chul Cho, Shun Lu, Myung Ah Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Jayesh Desai, Hui Gan, Catherine Barrow, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Internal Medicine Journal
|
September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Journal of Personalized Medicine
|
November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic
John P Parisot, Heather Thorne, Andrew Fellowes, et al.
Clinical Lung Cancer
|
September 20, 2024
Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator
Sanuki Tissera, Baki Billah, Margaret Brand, et al.
Clinical Colorectal Cancer
|
March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer
Hui-Li Wong, Belinda Lee, Kathryn Field, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study
Belinda Lee, Hui-Li Wong, Mark Tacey, et al.
Thoracic Cancer
|
September 11, 2025
Impact of Stage-Specific Guideline Concordant Treatment in Small Cell Lung Cancer in Victoria, Australia
Sanuki Tissera, Baki Billah, Md Nazmul Karim, et al.
Thoracic Cancer
|
February 23, 2026
The Association Between Health-Related Quality of Life Scores and Clinical Outcomes for People Living With Lung Cancer: An Australian Registry Cohort Study Using Patient-Reported Outcomes to Drive Value-Based Healthcare
Susan V Harden, Madeleine T King, Jing Jing Li, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
Luis Paz-Ares, Remi Veillon, Margarita Majem, et al.
Nature Medicine
|
April 29, 2025
D3S-001 in advanced solid tumors with KRAS<sup>G12C</sup> mutations: a phase 1 trial
Byoung Chul Cho, Shun Lu, Myung Ah Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Jayesh Desai, Hui Gan, Catherine Barrow, et al.
Page
of 6